ESC Professional Premium Access

Pacing innovations

Event: ESC Congress 2022
Topic: Device Therapy
Session type: Abstract Sessions
Date: 27 August 2022
Time: 10:15 - 11:15

Congress Session

6 presentations in this session

Clinical impact of "minimal" right ventricular pacing on atrial arrhythmias: results from the prospective multi-center worldwide EMERALD study.

Speaker: Doctor A. Di Cori (Pisa, IT)

Mortality and 30-day readmission rate following leadless pacemaker implantation: insights from the Nationwide Readmissions Database

Speaker: Doctor R. Tonegawa-Kuji (Suita, JP)

Chronic outcomes of leadless vs transvenous single chamber ventricular pacemakers in high-risk subgroups

Speaker: Mr L. Higuera (Mounds View, US)

Evaluation of the association between right ventricular lead placement and future need for upgrade from pacemaker or ICD to cardiac resynchronization therapy. A population-based comparative study

Speaker: Associate Professor R. Borgquist (Lund, SE)

Acute hemodynamic effects of biventricular pacing studied during cardiovascular magnetic resonance imaging: The PICARIA Trial

Speaker: Mr L. Hopman (Amsterdam, NL)

Intracardiac echocardiographically guided permanent pacemaker implantation is a feasible imaging tool with comparable procedural efficacy and safety

Speaker: Professor S. Shin (Seoul, KR)

6 speakers from this session

Doctor Andrea Di Cori

University Hospital of Pisa, Pisa (Italy)
1 follower

Doctor Reina Tonegawa-Kuji

National Cerebral & Cardiovascular Center, Suita (Japan)
0 follower

Mr Lucas Higuera

Medtronic, Mounds View (United States of America)
0 follower

Associate Professor Rasmus Borgquist

Skane University Hospital, Lund (Sweden)
6 presentations
0 follower

Mr Luuk Hopman

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

Professor Seung Yong Shin

Chung-Ang University Hospital, Seoul (Korea (Republic of))
0 follower

This platform is supported by

logo Novo Nordisk